Non-Current Assets

Equity Securities (Non-Current)

Regeneron Pharmaceuticals Equity Securities (Non-Current) increased by 42.0% to $48.70M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ1 2025
Last reportedQ4 2025
Metric ID: equity_securities_noncurrent

Historical Data

2 periods
 Q4 '25Q1 '26
Value$34.30M$48.70M
QoQ Change—+42.0%
Range$34.30M – $48.70M

Frequently Asked Questions

What is Regeneron Pharmaceuticals's equity securities (non-current)?
Regeneron Pharmaceuticals (REGN) reported equity securities (non-current) of $48.70M in Q1 2026.